Channing J Der
31PUBLICATIONS
262CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (31)
Sort by Publication Date:
|Jan 20, 2026
KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment.Rachel A Burge, Ozgun Le Roux, Olesja Popow
|Nov 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer.Szu-Aun Long, Haley Todd, Grace Goodhart
|Oct 24, 2025
Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.Mandana Kamgar, G Aaron Hobbes, Raven Davidson
|Sep 30, 2025
Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer.Priya S Hibshman, Clint A Stalnecker, Jeffrey A Klomp
|Sep 03, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer.Kathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker
Pageof 6
Frequent Collaborators
14 joint publications
Clint A Stalnecker
13 joint publications
Adrienne D Cox
11 joint publications
Andrew Waters
10 joint publications
Kirsten L Bryant
8 joint publications
G Aaron Hobbs
6 joint publications
Jeffrey A Klomp
6 joint publications
Kristina Drizyte-Miller
6 joint publications
Björn Papke
6 joint publications
Laura E Herring
5 joint publications
Craig M Goodwin
